首页> 外国专利> FUSION ANTIGEN WHICH IS USED IN MANUFACTURING DENDRITIC CELL VACCIEN FOR IMMUNOTHERAPY

FUSION ANTIGEN WHICH IS USED IN MANUFACTURING DENDRITIC CELL VACCIEN FOR IMMUNOTHERAPY

机译:用于制造树突状细胞疫苗进行免疫治疗的融合抗原

摘要

PURPOSE: A fusion antigen and a method for manufacturing a mature dendritic cell vaccine for immunotherapy using the same are provided to improve efficiency. ;CONSTITUTION: A fusion antigen used in manufacturing dendritic cell vaccine for immunotherapy contains PTD-MUC1 fusion protein containing MUC1(mucin antigen 1) fused to protein transduction domain(PTD) or PTD-Ag85A fusion protein. The fusion antigen is PTD-MUC1-Ag85A or PTD-Ag85A-MUC1. A method for manufacturing the dendritic cell vaccine comprises: a step of preparing immature dendritic cells; and a step of culturing the cells with the fusion antigen for maturing the cells. A pharmaceutical composition for anticancer immunotherapy contains pharmaceutically effective amount of the dendritic cell vaccine and pharmaceutically acceptable carrier.;COPYRIGHT KIPO 2011
机译:目的:提供融合抗原和使用该融合抗原制造用于免疫疗法的成熟树突细胞疫苗的方法,以提高效率。 ;组成:用于免疫疗法的树突状细胞疫苗生产的融合抗原包含PTD-MUC1融合蛋白,其中含有MUC1(粘蛋白抗原1)与蛋白转导域(PTD)或PTD-Ag85A融合蛋白融合。融合抗原是PTD-MUC1-Ag85A或PTD-Ag85A-MUC1。一种树突状细胞疫苗的制备方法,包括:制备未成熟树突状细胞的步骤;和用融合抗原培养细胞以使细胞成熟的步骤。用于抗癌免疫疗法的药物组合物包含药学上有效量的树突状细胞疫苗和药学上可接受的载体。; COPYRIGHT KIPO 2011

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号